Yash Dudhwala
- APID
- 9579
- ORCID
- 0009-0006-6043-5665
- Location
- Surat, Gujarat, India
- Expertise
- 3 years and 8 months
- Areas of interest
- Cancer targeted vesicular drug delivery system, Novel Drug Delivery system, Side effect reducing approaches for cancer drugs
- Member since
- March 2025
Biography
Dr. Yash Dudhwala is a dedicated pharmaceutical researcher and academician specializing in nanotechnology-driven drug delivery systems. With expertise in formulation science and targeted therapeutics, his research primarily focuses on the development, optimization, and characterization of nanoparticles to enhance drug solubility, bioavailability, and targeted delivery, particularly in oncology and geriatric/pediatric formulations.
Key Research Contributions:
Development of Febuxostat-loaded nanoparticles, utilizing Plackett-Burman screening and Box-Behnken optimization to improve drug delivery efficiency.
Engineering of ligand-functionalized nanoparticles (hyaluronic acid and folic acid conjugation) for receptor-mediated targeted drug delivery in colorectal and breast cancer.
Preparation of Imatinib Mesylate nanoparticles using the emulsion solvent evaporation method for dermatofibrosarcoma protuberans treatment.
Advances in silica-based nanoparticles for prostate cancer, exploring their potential for targeted therapy and theranostic applications.
Design and development of a medicine dispenser to optimize pill administration, integrating pharmaceutical sciences with technology.
Sign in to see editorial board appointments, follow, and connect.
Sign in